The core technology of Surface Plasmon Resonance (SPR) allows this instrument to become a veritable diagnostic laboratory by adhering specific ligands or antibodies to the gold particles on the sensor. These ligands then bind to the specific molecules, biomarkers, enzymes, proteins, viruses, bacteria, or chemicals the clinician wishes to detect in the tears. Using these smart prism sensors at point-of-care, the physician can diagnose and manage his patients efficiently and economically.
Recent research has discovered breast cancers specific biomarkers in tears. With such robust diagnostic capabilities of SPR in LacriPen™, the company is confident that it will afford an economical, accurate and efficient method to detect such novel biomarkers in current and future tear research.